Track Order   | Customer Support   | Request Book   |
International Order
Incretin Based Therapies at Meripustak

Incretin Based Therapies

Books from same Author: KALRA SANJAY

Books from same Publisher: Jaypee Brothers Medical Publishers

Related Category: Author List / Publisher List

  • Retail Price: ₹ 2325/- [ 15.00% off ]

    Seller Price: ₹ 1976

Sold By: T K Pandey      Click for Bulk Order

Offer 1: Get ₹ 111 extra discount on minimum ₹ 500 [Use Code: Bharat]

Offer 2: Get 15.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 15.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available


Click for International Orders
  • Provide Fastest Delivery
  • 100% Original Guaranteed
    • General Information  
    Author(s)KALRA SANJAY
    PublisherJaypee Brothers Medical Publishers
    Edition1
    ISBN9789350256480
    Pages190
    BindingPaper Back
    LanguageEnglish
    Publish YearJanuary 2013

    Description

    Jaypee Brothers Medical Publishers Incretin Based Therapies by KALRA SANJAY

    Multiple pharmacotherapeutic agents are now used in diabetology practice. The sheer scale of the permutations and combinations sometimes leaves practitioners confused as to their appropriate use. The major recent advance in diabetic drug therapy has been the development of incretin based therapies. These agents of varying chemical structures have changed our approach to diabetes care bringing with them an enhanced understanding of the pathophysiology and natural history of the disease. However they also bring with them a challenge for the diabetes care professional. Confronted with a wide choice of “newer” drugs the diabetes care provider feels the need for more information to write a rational prescription. This book fulfills this need. An easily readable and comprehensible lay out helps make complicated concepts look simple. Classification of incretin based therapy into different groups each discussed separately gives the reader clarity. For each group an overview chapter is followed by a focused discussion of various aspects of clinical pharmacology. While a section on the history and developments of incretin based therapy puts this novel class of drugs in perspective futuristic chapters on nondiabetic usage and combination therapy give a glimpse of their untapped potential.

    Key Features:-

    • A crisp overview of the latest and promosing drug class incretin based therapies in diabetes manage
    • Summarize the available evidence on various molecules in the class and their benefits and shortcomin
    • Relevant scientific information integrated throughout with a focus on providing practical therapeuti
    • Well conceived to meet the clinician's needs in the optimal management of the diabetic subject.
    • Gives a glimpse into the future potential of this class of drugs.